A detailed history of Janiczek Wealth Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 475 shares of UTHR stock, worth $172,026. This represents 0.03% of its overall portfolio holdings.

Number of Shares
475
Previous 482 1.45%
Holding current value
$172,026
Previous $110,000 37.27%
% of portfolio
0.03%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$228.26 - $319.04 $1,597 - $2,233
-7 Reduced 1.45%
475 $151,000
Q1 2024

Apr 15, 2024

BUY
$210.76 - $249.51 $17,703 - $20,958
84 Added 21.11%
482 $110,000
Q4 2023

Jan 26, 2024

SELL
$214.88 - $256.94 $644 - $770
-3 Reduced 0.75%
398 $87,000
Q3 2023

Oct 13, 2023

SELL
$211.82 - $248.24 $2,118 - $2,482
-10 Reduced 2.43%
401 $90,000
Q2 2023

Jul 11, 2023

BUY
$205.19 - $232.99 $7,181 - $8,154
35 Added 9.31%
411 $90,000
Q1 2023

Apr 21, 2023

SELL
$212.99 - $276.17 $2,768 - $3,590
-13 Reduced 3.34%
376 $84,000
Q4 2022

Jan 20, 2023

BUY
$205.95 - $280.43 $2,677 - $3,645
13 Added 3.46%
389 $0
Q3 2022

Oct 17, 2022

SELL
$203.3 - $244.17 $1,219 - $1,465
-6 Reduced 1.57%
376 $77,000
Q2 2022

Aug 03, 2022

SELL
$174.81 - $241.14 $2,447 - $3,375
-14 Reduced 3.54%
382 $88,000
Q1 2022

May 05, 2022

SELL
$166.16 - $213.96 $8,640 - $11,125
-52 Reduced 11.61%
396 $71,000
Q4 2021

Feb 02, 2022

BUY
$184.32 - $216.08 $2,211 - $2,592
12 Added 2.75%
448 $97,000
Q3 2021

Oct 19, 2021

BUY
$179.86 - $214.88 $16,726 - $19,983
93 Added 27.11%
436 $80,000
Q2 2021

Jul 28, 2021

BUY
$170.47 - $211.93 $852 - $1,059
5 Added 1.48%
343 $62,000
Q1 2021

Apr 28, 2021

BUY
$153.94 - $174.85 $14,316 - $16,261
93 Added 37.96%
338 $57,000
Q4 2020

Jan 26, 2021

BUY
$101.87 - $151.79 $22,105 - $32,938
217 Added 775.0%
245 $37,000
Q3 2020

Oct 19, 2020

BUY
$99.9 - $121.13 $2,797 - $3,391
28 New
28 $3,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.